Neurodiagnostics company receives US patent for electrode interface device

A firm specializing in brain-computer interface has received a U.S. patent for its Medusa Electrode, which translates specific neuromodulation connections into universal electroencephalography plugs.

According to a release from Threshold NeuroDiagnostics, the interface device allows access to more than 70,000 invasive electrodes that assist in anatomical localization and biomarker access.

Its plug converter additionally enables seamless integration between the human central nervous system and neurophysiology equipment, which may have positive clinical applications as well as possibilities for future expanded research, per the release.

“Our goal is to leverage the human neural network to address a broad spectrum of neurological issues, and securing this patent is a key milestone in that journey,” Threshold founder Geoffrey Allott, BA, CNIM, said in the release. “The Medusa Electrode is an integral step in creating ‘closed-loop’ neuromodulation systems, similar to a nervous system pacemaker, (which) demonstrates our focus on creating simple and flexible solutions that have a profound impact on neuromodulation research and therapies.”